NMN Dosage in 2026: How Much NMN to Take Daily
The dose range used in human studies, why 600 mg keeps coming up, when to take it, and how NMN differs from NAD+ itself.
Most human studies use 300 to 900 mg of NMN a day, taken once in the morning. In the largest dose-response trial, 600 mg a day raised blood NAD+ and walking distance the most, and 900 mg did no better. Newcomers often start near 250 to 300 mg and build up. NMN is an oral supplement, not a prescription. pru does not offer NMN, and offers NAD+ by injection, the coenzyme NMN is meant to raise.
How much NMN should you take?
A common daily NMN dose in human studies is 300 to 900 mg, taken once in the morning. In a 2023 dose-response trial of 80 adults aged 40 to 65, 600 mg a day raised blood NAD+ and six-minute walking distance the most. The 900 mg group did no better than 600 mg, and 300 mg lagged both. That points to 600 mg as a reasonable target for most people, with a lower start for newcomers.
How popular is NMN?People search for NMN about 35,000 times a month in the US, a widely searched peptide (2026 search data). See the Peptide Popularity Report for the full ranking.
- Newcomer start: 250 to 300 mg once daily for the first few weeks
- Common target: 500 to 600 mg once daily
- Upper range studied: up to 900 to 1,200 mg a day, with no clear extra benefit over 600 mg
- When: morning, on an empty stomach for standard capsules
The short answer600 mg a day is the dose that raised NAD+ and physical performance the most in the main dose-response study. Start lower, stay consistent, and talk with your clinician before adding any supplement.
NMN dose ranges seen in studies
Human NMN trials have tested a wide band, roughly 150 to 1,200 mg a day, over two weeks to twelve weeks. The table below groups the doses people commonly use and what the research attached to each. These are study amounts, not a prescription or a promise of any result.
| Daily dose | Who it fits | What studies looked at |
|---|---|---|
| 250-300 mg | Newcomers, first weeks | Raised blood NAD+; smallest change in walking distance in the dose-response trial |
| 500-600 mg | Most active adults 45-65 | Largest rise in NAD+ and six-minute walk distance; a common target dose |
| 900 mg | People chasing a higher dose | No measurable gain over 600 mg in the dose-response trial |
| 1,000-1,200 mg | Studied upper end | Tested for safety; no serious adverse effects reported, no clear extra benefit |
NMN is thought to work as a precursor, a raw material the body converts toward NAD+. Doses above 600 mg have not shown a clear added effect in the endurance data so far, so more is not automatically better.
What NMN is and how it is thought to work
NMN, short for nicotinamide mononucleotide, is a molecule your cells use on the path to making NAD+. NAD+ is a coenzyme every cell needs for energy and repair, and its levels tend to fall with age. NMN is studied as one way to nudge NAD+ back up. It is sold as an oral supplement, so it has to survive digestion before your body converts it.

When should you take NMN?
Morning is the common choice, because the body's own NAD+ tends to rise early in the day and NMN is thought to work with that rhythm. For standard capsules, an empty stomach is the more defensible pick, since stomach acid can degrade NMN. Delayed-release or sublingual forms care less about food. The biggest factor is consistency, so pick a time you will keep every day.
- Standard capsule: morning, empty stomach, then wait 20 to 30 minutes before food
- Sensitive stomach or higher dose: take with a small breakfast
- Splitting: some people take half in the morning and half at midday, though data on splitting is thin
- Avoid late evening if it disrupts your sleep
One habit beats perfect timingTaking NMN at the same time every day matters more than the exact hour. A dose you remember is better than an optimal dose you skip.
Is NMN safe, and what are the side effects?
In human trials, NMN has been well tolerated. A safety study dosed healthy adults up to 1,200 mg a day and reported no serious adverse effects, and 1,250 mg once daily was tolerated for up to four weeks. Most reported issues are mild and short-lived. NMN is a supplement, so quality and purity vary by brand, which is a bigger practical concern than the molecule itself.
- Reported mild effects: nausea, indigestion, headache, or flushing, usually at higher doses
- Unknowns: long-term effects beyond several months are still being studied
- Interactions: talk with your clinician if you take prescription medicines or manage a chronic condition
- Quality: pick brands with third-party testing and a clear certificate of analysis
NMN is thought to support energy and healthy aging, and the evidence in older adults is growing but still early. None of this is a claim to treat, cure, or prevent any disease.
NMN vs NAD+: why the difference matters
NMN is a precursor you swallow. NAD+ is the finished coenzyme. An oral NMN capsule asks your gut and cells to do the conversion. NAD+ given by injection delivers the coenzyme itself and skips digestion, which is a different product category with a different access path. pru does not offer NMN; pru offers NAD+ by injection and glutathione by injection through licensed prescribers and pharmacies.
If your goal is raising NAD+, both paths aim at the same target from different directions. For a fuller comparison, see the NMN vs NAD+ and NAD+ delivery reads in the related section below.
NMN quality and its 2026 legal status
NMN's regulatory footing shifted in 2025. In letters dated September 29, 2025, the FDA reversed its earlier position and confirmed NMN is not excluded from the definition of a dietary supplement, and by December 2025 reinstated its new-dietary-ingredient status. So NMN can be sold as a supplement in the U.S. again. It is still a supplement, not an FDA-approved drug, and not a pharmacy-compounded prescription.
- Buy from brands with third-party purity and identity testing
- Look for a batch certificate of analysis, since NMN degrades with heat and moisture
- Store cool and sealed
- Treat bold anti-aging promises on a label as marketing, not proof
How pru handles NMN and NAD+
pru is a telehealth platform for compounded peptides and closely related longevity therapies. A physician confirms clinical fit, and an FDA-regulated 503A pharmacy fills what is prescribed. Membership runs about $50 a month, and any therapy is sold separately at cost, itemized, with no markup.
You select what interests you; the prescriber confirms whether it fits. Getting ahead of how you age is a smart, responsible instinct, and pru exists to make that informed choice accessible: licensed physicians, pharmacy-grade medicine, and at-cost pricing put the smart path within reach.
- NMN and spermidine are oral supplements and precursors, not prescriptions, so pru does not offer them; this page is educational
- pru offers NAD+ by injection and nasal spray, the coenzyme NMN is meant to raise, prescribed by a physician and filled by a licensed pharmacy
- pru also offers glutathione by injection in the same cellular-health lane
- Epitalon is planned, pending the FDA PCAC review on July 23 to 24, 2026, and would be offered the right way, physician-prescribed and 503A-compounded, if that pathway opens
Where to start with pruIf NAD+ support is your goal, the physician-prescribed NAD+ injection is the pru product closest to what NMN aims at. Browse the cellular-health lane to compare, and take the next step when you are ready.
Related reading
Keep going with these guides on NMN, NAD+, and cellular-health longevity.
- NMN benefits, explained
- NMN vs NAD+: which is which
- Where to buy NMN safely
- NAD+ for energy and brain fog
- NAD+ injection vs IV vs oral
- Best peptides for longevity
- See the pru blog
Common questions
Sources & further reading
- https://pmc.ncbi.nlm.nih.gov/articles/PMC11365583/
- https://www.nature.com/articles/s41598-023-29787-3
- https://pmc.ncbi.nlm.nih.gov/articles/PMC11557618/
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400576/
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265078/
- https://www.venable.com/insights/publications/2025/10/fda-declares-nicotinamide-mononucleotide-is
- joinpru.com/shop/product/nad
- joinpru.com/blog